Researcher Database

Tsuboya Ayako

FacultyHospital Pharmaceutics
PositionSenior Lecturer
Last Updated :2026/08/17

Researcher

基本情報

Profile and Settings

  • 氏名

    Tsuboya Ayako

Affiliation

  • Hospital Pharmaceutics, Senior Lecturer

Location

  • Hatanodai Campus

Degree

  • Doctor of Pharmaceutical Science, Showa University, Mar. 2019

Achievements

Published Papers

  • Effectiveness of Statins for Oxaliplatin-Induced Peripheral Neuropathy: A Multicenter Retrospective Observational Study, Kenshi Takechi, Takehiro Kawashiri, Keisuke Mine, Soichiro Ushio, Hirofumi Hamano, Noriko Hida, Kenji Momo, Masanobu Uchiyama, Mami Uchida, Mamoru Tanaka, Noriaki Hidaka, Hideki Yasui, Masahiro Ueda, Ryohei Fujii, Misaki Hashimoto, Yasutaka Sakamoto, Kana Uyama, Takahiro Niimura, Yuki Hanai, Ayaka Tsuboya, Keisuke Suzuki, Naoya Kamiyama, Hiromi Hagiwara, Naoto Okada , Yoshito Zamami, Keisuke Ishizawa, Clin Transl Sci, 18(10):e70318, Oct. 2025, Peer-reviewed, DOI:10.1111/cts.70318
  • Atypical Femoral Fracture in Patients With Metastatic Bone Tumors: An Analysis Based on the Japanese Adverse Drug Event Reaction Database (JADER), Yuka Aimono, Tomiko Sunaga, Ryo Yonezawa, Ayako Tsuboya, Mari Kogo, Cureus, 17(5):e84126, May 2025, Peer-reviewed, DOI:10.7759/cureus.84126
  • Atypical Femoral Fracture During Long-Term Treatment With Denosumab in Patients With Metastatic Bone Tumors, Yuka Aimono, Tomiko Sunaga, Ryo Yonezawa, Ayako Tsuboya, Mari Kogo, Ako Itoh, Cureus, 17(5):e85052, May 2025, Peer-reviewed, DOI:10.7759/cureus.85052
  • Medication Optimization Protocol Efficacy for Geriatric Inpatients: A Randomized Clinical Trial, Kenya Ie, Masanori Hirose, Tsubasa Sakai, Iori Motohashi, Mari Aihara, Takuya Otsuki, Ayako Tsuboya, Hiroshi Matsumoto, Hikari Hashi, Eisuke Inoue, Masaki Takahashi, Eiko Komiya, Yuka Itoh, Reiko Machino, Tomoya Tsuchida, Steven M Albert, Yoshiyuki Ohira, Chiaki Okuse, JAMA Netw Open, 7(7):e2423544, Jul. 2024, Peer-reviewed, DOI:10.1001/jamanetworkopen.2024.23544
  • Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial), Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura, Hitoshi Arioka, Hirotoshi Iihara, Mitsuhiro Sugawara, Hajime Morita, Ayako Mochizuki, Shuichi Nawata, Keisuke Mishima, Ayako Tsuboya, Tempei Miyaji, Kazunori Honda, Ayako Yokomizo, Naoya Hashimoto, Takeshi Yanagihara, Junki Endo, Takashi Kawaguchi, Naoki Furuya, Yumiko Sone, Yusuke Inada, Yasushi Ohno, Chikatoshi Katada, Naoya Hida, Kana Akiyama, Daisuke Ichikura, Akiko Konomatsu, Takashi Ogura, Takuhiro Yamaguchi, Takako Eguchi Nakajima, Br J Cancer, 130(2):224 - 232, Nov. 2023, Peer-reviewed, DOI:10.1038/s41416-023-02493-7
  • Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure., TSUBOYA Ayako;KUBOTA Yutaro;ISHIDA Hiroo;OHKUMA Ryotaro;ISHIGURO Tomoyuki;HIRASAWA Yuya;ARIIZUMI Hirotsugu;TSUNODA Takuya;SASAKI Yasutsuna;MATSUMOTO Natsumi;KONDO Yusuke;TOMODA Yukana;KUSUHARA Hiroyuki;FUJITA Ken-ichi, Cancer Chemother Pharmacol, 88(3):543 - 553, Jun. 2021, Peer-reviewed, DOI:10.1007/s00280-021-04314-1
  • Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1-4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy, Hiroko Minatogawa, Naoki Izawa, Takashi Kawaguchi, Tempei Miyaji, Kazuhiro Shimomura, Honda Kazunori, Hirotoshi Iihara, Yasushi Ohno, Yusuke Inada, Hitoshi Arioka, Hajime Morita, Naoya Hida, Mitsuhiro Sugawara, Chikatoshi Katada, Shuichi Nawata, Hiroo Ishida, Ayako Tsuboya, Takashi Tsuda, Takuhiro Yamaguchi, Takako Eguchi Nakajima, BMJ Open, 10(12):e041737, Dec. 2020, Peer-reviewed, DOI:10.1136/bmjopen-2020-041737
  • Protocol of a randomised controlled trial on the efficacy of medication optimisation in elderly inpatients: medication optimisation protocol efficacy for geriatric inpatients (MPEG) trial, Kenya Ie, Masanori Hirose, Tsubasa Sakai, Iori Motohashi, Mari Aihara, Takuya Otsuki, Ayako Tsuboya, Hiroshi Matsumoto, Hikari Hashi, Eisuke Inoue, Masaki Takahashi, Eiko Komiya, Yuka Itoh, Tomoya Tsuchida, Eri Kurosu, Steven M Albert, Chiaki Okuse, Takahide Matsuda, BMJ Open, 10(10):e041125, Oct. 2020, Peer-reviewed, DOI:10.1136/bmjopen-2020-041125
  • Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer., TSUBOYA Ayako;FUJITA Ken-ichi;KUBOTA Yutaro;ISHIDA Hiroo;TAKI (TAKEMOTO) Iori;KAMEI Daisuke;IWAI Shinichi;SASAKI Yasutsuna, Int J Clin Oncol, 24(2):222 - 230, Feb. 2019, Peer-reviewed
  • Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy, Yuka Ito, Takashi Tsuda, Hiroko Minatogawa, Sayaka Kano, Kentaro Sakamaki, Masahiko Ando, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, Sadatoshi Sugae, Ichiro Ohta, Hitoshi Arioka, Yutaka Tokuda, Kazutaka Narui, Ayako Tsuboya, Takashi Suda, Satoshi Morita, Narikazu Boku, Takeharu Yamanaka, Takako Eguchi Nakajima, J Clin Oncol, 36(10):1000 - 1006, Feb. 2018, Peer-reviewed, DOI:10.1200/JCO.2017.74.4375
  • Predictors of restenosis after coronary artery stenting., Yoneyama K, Tsuboya A, Kogo M, Kiuchi Y, Takeyama Y., Minerva Cardioangiol, 56(3):295 - 305, Jun. 2008, Peer-reviewed, DOI:Minerva Cardioangiol

Presentations

  • SN-38の体内動態とOATP1B1の機能:重篤な腎機能障害のない患者において, 藤田 健一;久保田 祐太郎;石田 博雄;坪谷 綾子;角田 卓也;松本 奈都美;楠原 洋之;佐々木 康綱, 第18回日本臨床腫瘍学会学術集会 (JSMO2021), 18 Feb. 2021, オンデマンド配信
  • 抗悪性腫瘍薬イリノテカンの活性代謝物SN-38の体内動態とOATP1B1輸送活性との関連, 藤田 健一;久保田 祐太郎;石田 博雄;坪谷 綾子;角田 卓也;松本 奈都美;楠原 洋之;佐々木 康綱, 第41回日本臨床薬理学会学術総会, 05 Dec. 2020, 福岡およびWeb会場


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.